EXOSOME DIAGNOSTICS
Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technology makes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.
EXOSOME DIAGNOSTICS
Industry:
Biotechnology Genetics Health Care Health Diagnostics
Founded:
2008-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.exosomedx.com
Total Employee:
101+
Status:
Active
Contact:
1(617) 588-0500
Email Addresses:
[email protected]
Total Funding:
112.08 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
AltheaDx
AltheaDx offers molecular diagnostics and PCR-based services such as molecular biomarker discovery, assay development and assay validation.
Cofactor Genomics
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
CareDx
CareDx is a novel molecular diagnostics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Forbion Capital Partners
Forbion Capital Partners investment in Series C - Exosome Diagnostics
btov Partners
btov Partners investment in Series C - Exosome Diagnostics
CD-Venture
CD-Venture investment in Series C - Exosome Diagnostics
Blue Ridge Capital
Blue Ridge Capital investment in Series C - Exosome Diagnostics
NGN Capital
NGN Capital investment in Series C - Exosome Diagnostics
Tiger Infrastructure Partners
Tiger Infrastructure Partners investment in Series C - Exosome Diagnostics
Arcus Ventures
Arcus Ventures investment in Series C - Exosome Diagnostics
Tiger Management Corporation
Tiger Management Corporation investment in Series B - Exosome Diagnostics
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Exosome Diagnostics
Arcus Ventures
Arcus Ventures investment in Series B - Exosome Diagnostics
Official Site Inspections
http://www.exosomedx.com Semrush global rank: 2.29 M Semrush visits lastest month: 8.23 K
- Host name: a23-1-44-100.deploy.static.akamaitechnologies.com
- IP address: 23.1.44.100
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
